A team of scientists from Melbourne, Europe and the United States has identified a genetic variation that influences stroke patients' recovery.
The Centre for Invasive Species Solutions has brought together five state and territory governments, three local councils, three universities and three private environmental groups to form Australia's largest deer management research collaboration.
An investigation published by The BMJ raises fundamental questions about the transparency of information surrounding the safety of GlaxoSmithKline's Pandemrix vaccine used in 2009–2010.
The PCR-based method will improve monitoring and early detection of the reef pest, allowing reef managers to contain outbreaks sooner.
Melbourne researchers have revealed that a key player in the initiation, and pain, of migraines is a neuropeptide called calcitonin gene-related peptide (CGRP).
Macquarie University scientists have received a $1.1 million grant from ARENA for a project to engineer bacteria that turn sugar into hydrogen.
Researchers have developed a new selection tool that facilitates delivery of smart drugs into cells to battle hard-to-treat diseases such as cancer and Duchenne Muscular Dystrophy.
A new method helps detect early-stage cancer tumour cells in the blood using a malaria protein.
Citizen scientists are taking part in Virtual Reef Diver, a project that is helping scientists and reef managers get a better picture of the health of the Great Barrier Reef.
Renowned international plant biologist Keiko Torii will present the Annals of Botany Lecture at ComBio2018, a major Australian Society for Biochemistry and Molecular Biology (ASBMB) conference.
A Nobel prize-winning American cell biologist talks about extracellular vesicles (EVs), exciting developments in the field and the challenges facing scientific publishing.
Humans have been identified as the original hosts for the bacteria Staphylococcus aureus, commonly known as golden staph, according to an international study.
An international team of scientists have returned from a once-in-a-lifetime expedition that took them 400 km north-east of New Zealand.
The fight against cystic fibrosis (CF) has taken a major step forward, with researchers showing that cells causing this genetic disorder could be successfully replaced with healthy ones.
Australian researchers have identified a new mechanism used by Henipaviruses in infection, and potential new targets for antivirals to treat them.